THE ANTI-TUMOR EFFICACY OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 INVIVO

[1] Anderson R E, 1976, Adv Immunol, V24, P215, DOI 10.1016/S0065-2776(08)60331-4

[2] BAINBRIDGE D. R., 1966, TRANSPLANTATION, V4, P138, DOI 10.1097/00007890-196603000-00003

[3] ELIMINATION OF ALLOGENEIC LYMPHOCYTES BY MICE [J]. IMMUNOLOGICAL REVIEWS, 1983, 73 : 5 - 34

[4] BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69

[5] INHIBITION OF ESTABLISHED TRANSPLANTS OF CHEMICALLY INDUCED SARCOMAS IN SYNGENEIC MICE BY LYMPHOCYTES FROM IMMUNIZED DONORS [J]. INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (03) : 539 - &

[6] CHANG AE, 1984, J BIOL RESP MODIF, V3, P561

[7] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980

[8] CHEEVER MA, 1977, J IMMUNOL, V119, P714

[9] CHEEVER MA, 1984, J IMMUNOL, V132, P2259

[10] DONOHUE JH, 1984, J IMMUNOL, V132, P2123

[1] Anderson R E, 1976, Adv Immunol, V24, P215, DOI 10.1016/S0065-2776(08)60331-4

[2] BAINBRIDGE D. R., 1966, TRANSPLANTATION, V4, P138, DOI 10.1097/00007890-196603000-00003

[3] ELIMINATION OF ALLOGENEIC LYMPHOCYTES BY MICE [J]. IMMUNOLOGICAL REVIEWS, 1983, 73 : 5 - 34

[4] BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69

[5] INHIBITION OF ESTABLISHED TRANSPLANTS OF CHEMICALLY INDUCED SARCOMAS IN SYNGENEIC MICE BY LYMPHOCYTES FROM IMMUNIZED DONORS [J]. INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (03) : 539 - &

[6] CHANG AE, 1984, J BIOL RESP MODIF, V3, P561

[7] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980

[8] CHEEVER MA, 1977, J IMMUNOL, V119, P714

[9] CHEEVER MA, 1984, J IMMUNOL, V132, P2259

[10] DONOHUE JH, 1984, J IMMUNOL, V132, P2123